000 01551 a2200397 4500
005 20250514210448.0
264 0 _c20050318
008 200503s 0 0 eng d
022 _a1567-5688
024 7 _a10.1016/j.atherosclerosissup.2004.08.023
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMabuchi, Hiroshi
245 0 0 _aEffects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.
_h[electronic resource]
260 _bAtherosclerosis. Supplements
_cOct 2004
300 _a51-5 p.
_bdigital
500 _aPublication Type: Biography; Classical Article; Historical Article; Journal Article
650 0 4 _aAnticholesteremic Agents
_xhistory
650 0 4 _aCoenzymes
650 0 4 _aHistory, 20th Century
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xhistory
650 0 4 _aHyperlipoproteinemia Type II
_xblood
650 0 4 _aLipoproteins
_xblood
650 0 4 _aLovastatin
_xanalogs & derivatives
650 0 4 _aUbiquinone
_xanalogs & derivatives
700 1 _aHaba, Toshihiro
700 1 _aTatami, Ryzo
700 1 _aMiyamoto, Susumu
700 1 _aSakai, Yasuyuki
700 1 _aWakasugi, Takanobu
700 1 _aWatanabe, Akira
700 1 _aKoizumi, Junji
700 1 _aTakeda, Ryoyu
773 0 _tAtherosclerosis. Supplements
_gvol. 5
_gno. 3
_gp. 51-5
856 4 0 _uhttps://doi.org/10.1016/j.atherosclerosissup.2004.08.023
_zAvailable from publisher's website
999 _c15218862
_d15218862